BIOMARKER:

PD-1 expression

Entrez ID:

Related biomarkers:

‹

›

PD-1 expression PD-1 expression	Bladder Cancer Bladder Cancer	PD-1 expression PD-1 expression	Bladder Cancer Bladder Cancer	cisplatin Sensitive: C2 – Inclusion Criteria	cisplatin Sensitive: C2 – Inclusion Criteria
PD-1 expression PD-1 expression	Urothelial Cancer Urothelial Cancer	PD-1 expression PD-1 expression	Urothelial Cancer Urothelial Cancer	pembrolizumab + GSK3359609 Sensitive: C3 – Early Trials	pembrolizumab + GSK3359609 Sensitive: C3 – Early Trials
PD-1 expression PD-1 expression	Renal Cell Carcinoma RCC	PD-1 expression PD-1 expression	Renal Cell Carcinoma RCC	nivolumab Sensitive: C3 – Early Trials	nivolumab Sensitive: C3 – Early Trials
PD-1 expression PD-1 expression	Renal Cell Carcinoma RCC	PD-1 expression PD-1 expression	Renal Cell Carcinoma RCC	toripalimab Sensitive: C3 – Early Trials	toripalimab Sensitive: C3 – Early Trials
PD-1 expression PD-1 expression	Merkel Cell Carcinoma Merkel Cell Carcinoma	PD-1 expression PD-1 expression	Merkel Cell Carcinoma Merkel Cell Carcinoma	Immunotherapy Sensitive: C3 – Early Trials	Immunotherapy Sensitive: C3 – Early Trials
PD-1 expression PD-1 expression	Melanoma Melanoma	PD-1 expression PD-1 expression	Melanoma Melanoma	toripalimab Sensitive: D – Preclinical	toripalimab Sensitive: D – Preclinical